InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: FlyFishingStocks post# 182070

Wednesday, 03/20/2019 12:31:03 PM

Wednesday, March 20, 2019 12:31:03 PM

Post# of 426330
I'd rather they take the time to get it right and still beat the deadline they gave than to rush it and screw it up.
The MOA question doe snot seem to be a question anymore, FDA will look at it but there is no science behind it whatsoever and even the most ardent critic agrees it did not account for Vascepa working vs not working just enhanced its success.

This should easily get expedited review, it meets all the criteria and then some, it would be a huge surprise and huge negative if they did not receive expedited review.

The main negative argument is the results were too good, must not be good results despite JELIS, despite all the science saying it would work as well as it did. just ignorance really but also a very small minority.

I don;t like CEO's protecting the stock, execute, grow value and stock goes up
Stock was 4.00 to end 2017, then 13.61 to end 2018 and currently over 18.

People need to dumb down expectations, stocks don't just go straight up every day, this stock is trending long term up and there are many positive catalyst coming the rest of the year and not much in terms of likely negatives.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News